Literature DB >> 15886226

Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects.

Reawika Chaikomin1, Selena Doran, Karen L Jones, Christine Feinle-Bisset, Deirdre O'Donovan, Christopher K Rayner, Michael Horowitz.   

Abstract

The rate of gastric emptying of glucose-containing liquids is a major determinant of postprandial glycemia. The latter is also dependent on stimulation of insulin secretion by glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). Although overall emptying of glucose approximates 1-3 kcal/min, the "early phase" of gastric emptying is usually more rapid. We have evaluated the hypothesis that increased stimulation of incretin hormones and insulin by a more rapid initial rate of small intestinal glucose delivery would reduce the overall glycemic response to a standardized enteral glucose load. Twelve healthy subjects were studied on two separate days in which they received an intraduodenal (id) glucose infusion for 120 min. On one day, the infusion rate was variable, being more rapid (6 kcal/min) between t = 0 and 10 min and slower (0.55 kcal/min) between t = 10 and 120 min, whereas on the other day the rate was constant (1 kcal/min) from t = 0-120 min, i.e., on both days 120 kcal were given. Between t = 0 and 75 min, plasma insulin, GIP, and GLP-1 were higher with the variable infusion. Despite the increase in insulin and incretin hormones, blood glucose levels were also higher. Between t = 75 and 180 min, blood glucose and plasma insulin were lower with the variable infusion. There was no difference in the area under the curve 0-180 min for blood glucose. We conclude that stimulation of incretin hormone and insulin release by a more rapid initial rate of id glucose delivery does not lead to an overall reduction in glycemia in healthy subjects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15886226     DOI: 10.1152/ajpendo.00099.2005

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  24 in total

1.  Low-glycemic load decreases postprandial insulin and glucose and increases postprandial ghrelin in white but not black women.

Authors:  Kimberly A Brownley; Steve Heymen; Alan L Hinderliter; Joseph Galanko; Beth Macintosh
Journal:  J Nutr       Date:  2012-05-30       Impact factor: 4.798

2.  Gastric emptying of orally administered glucose solutions and incretin hormone responses are unaffected by laparoscopic adjustable gastric banding.

Authors:  Lotte Usinger; Katrine B Hansen; Viggo B Kristiansen; Steen Larsen; Jens J Holst; Filip K Knop
Journal:  Obes Surg       Date:  2011-05       Impact factor: 4.129

3.  Prospective evaluation of insulin and incretin dynamics in obese adults with and without diabetes for 2 years after Roux-en-Y gastric bypass.

Authors:  Jonathan Q Purnell; Geoffrey S Johnson; Abdus S Wahed; Chiara Dalla Man; Francesca Piccinini; Claudio Cobelli; Ronald L Prigeon; Bret H Goodpaster; David E Kelley; Myrlene A Staten; Karen E Foster-Schubert; David E Cummings; David R Flum; Anita P Courcoulas; Peter J Havel; Bruce M Wolfe
Journal:  Diabetologia       Date:  2018-02-10       Impact factor: 10.122

Review 4.  Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.

Authors:  Robert E Steinert; Christine Feinle-Bisset; Lori Asarian; Michael Horowitz; Christoph Beglinger; Nori Geary
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

5.  Increased nutrient sensitivity and plasma concentrations of enteral hormones during duodenal nutrient infusion in functional dyspepsia.

Authors:  Adil E Bharucha; Michael Camilleri; Duane D Burton; Shannon L Thieke; Kelly J Feuerhak; Ananda Basu; Alan R Zinsmeister
Journal:  Am J Gastroenterol       Date:  2014-11-18       Impact factor: 10.864

6.  Blockade of glucagon-like peptide 1 receptor corrects postprandial hypoglycemia after gastric bypass.

Authors:  Marzieh Salehi; Amalia Gastaldelli; David A D'Alessio
Journal:  Gastroenterology       Date:  2013-12-04       Impact factor: 22.682

Review 7.  Diabetic gastroparesis: diagnosis and management.

Authors:  Jing Ma; Christopher K Rayner; Karen L Jones; Michael Horowitz
Journal:  Drugs       Date:  2009-05-29       Impact factor: 9.546

8.  Effect of glycemic load on peptide-YY levels in a biracial sample of obese and normal weight women.

Authors:  Kimberly A Brownley; Steve Heymen; Alan L Hinderliter; Beth MacIntosh
Journal:  Obesity (Silver Spring)       Date:  2009-10-29       Impact factor: 5.002

9.  Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes.

Authors:  Blandine Laferrère; Julio Teixeira; James McGinty; Hao Tran; Joseph R Egger; Antonia Colarusso; Betty Kovack; Baani Bawa; Ninan Koshy; Hongchan Lee; Kimberly Yapp; Blanca Olivan
Journal:  J Clin Endocrinol Metab       Date:  2008-04-22       Impact factor: 5.958

10.  Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass.

Authors:  J Korner; W Inabnet; G Febres; I M Conwell; D J McMahon; R Salas; C Taveras; B Schrope; M Bessler
Journal:  Int J Obes (Lond)       Date:  2009-05-05       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.